NXGL
NEXGEL, INC. · Healthcare
Insiders sold $21K net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Jun 23, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$47K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Jun 23, 2026
Levy Adam R.
NEXGEL, INC. (NXGL) has 7 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 23, 2026.
Inside the rolling window, 1 insider at NEXGEL, INC. reported no open-market purchases and 12 open-market sales totaling $47K. The most active filer is Chief Executive Officer Levy Adam R. with 12 filings. The most recent open-market filing is a sale of 6,000 shares by Chief Executive Officer Levy Adam R., dated Jun 18, 2026, worth $4K.
- Industry:Medical - Instruments & Supplies
- CEO:Brian J. Kieser
- Employees:19
- HQ:Langhorne, PA, US
- IPO:2021-12-22
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 6,000 | $4K | Jun 23 | -52.4% | SEC ↗ | |
| Chief Executive Officer | Sale | 5,000 | $3K | Jun 23 | -52.4% | SEC ↗ | |
| Chief Executive Officer | Sale | 3,000 | $2K | Jun 15 | -50.3% | SEC ↗ | |
| Chief Executive Officer | Sale | 3,000 | $2K | Jun 9 | -54.3% | SEC ↗ | |
| Chief Executive Officer | Sale | 3,000 | $2K | Jun 9 | -54.3% | SEC ↗ | |
| Chief Executive Officer | Sale | 2,000 | $1K | Jun 3 | -54.6% | SEC ↗ | |
Levy Adam R.First in 5 months | Chief Executive Officer | Sale | 3,000 | $2K | May 30 | -55.2% | SEC ↗ |
Levy Adam R.First in 5 months | Chief Executive Officer | Sale | 7,000 | $4K | May 30 | -55.2% | SEC ↗ |
Levy Adam R.First in 5 months | Chief Executive Officer | Sale | 3,000 | $2K | May 30 | -55.2% | SEC ↗ |
| Chief Executive Officer | Sale | 6,000 | $10K | Dec 29 | -82.0% | SEC ↗ | |
| Chief Executive Officer | Sale | 4,000 | $6K | Dec 29 | — | SEC ↗ | |
Levy Adam R.First filing | Chief Executive Officer | Sale | 4,000 | $10K | Nov 7 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does NXGL have?
NEXGEL, INC. (NXGL) has 7 SEC Form 4 filings (12 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Jun 23, 2026.
When was the most recent SEC Form 4 filing for NXGL?
The most recent Form 4 filing for NXGL on Tracefour is dated Jun 23, 2026.
Who is the most active insider at NXGL?
The most active SEC Form 4 filer at NXGL in the rolling window is Chief Executive Officer Levy Adam R., with 12 filings.
What is the net insider flow at NXGL over the last 6 months?
Over the trailing 180 days, insiders at NXGL have net sold $37K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at NXGL in the current window?
Inside the rolling window, insiders at NXGL bought $0 and sold $47K based on SEC Form 4 filings.
Can I get alerts for NXGL insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at NEXGEL, INC. (NXGL). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
NEXGEL, INC. is in the Healthcare sector.